LabTIE by MolGen

Press Release: MolGen acquires LabTIE International

Veenendaal, March 02, 2021 – Today, MolGen, specializing in molecular biology and DNA/RNA extraction and laboratory automation, has announced its acquisition of LabTIE International. With this acquisition, MolGen strengthens its position in offering complete solutions for the Ag biotech and the life sciences markets.

Maarten de Groot, CEO of MolGen: “The acquisition was a result of a long-standing and trusted relationship between MolGen and LabTIE International. With this acquisition, we are adding innovative products to our portfolio. This is an important step in our mission to offer complete solutions for our customers.”

MolGen will retain the LabTIE brand name to ensure familiarity. “For LabTIE International’s customers it will be ‘business as usual’ as we will continue to improve our products and offerings with a strong customer focus” says Bas Millenaar, the former owner of LabTIE International, who was appointed as CEO of MolGen Production, where the product development of MolGen takes place. “We are looking forward to offering new products in the future to meet our customers’ demands.”

The acquisition was another big step in the on-going development of MolGen, who have been involved in providing extraction chemistry and equipment for scaling up SARS-CoV-2 test capacity in co-operation with the key stakeholders in the Netherlands, as well as many other countries globally.

MolGen is a global total solution provider of innovative extraction DNA/RNA technology, systems, products and kits for human and animal diagnostics, the agriculture and biotech industries. MolGen’s, systems, reagents and consumables reduce hands-on time and increase productivity while maintaining high yields and reproducibility. From sample to result, MolGen is challenging the status quo in molecular diagnostics by offering platform stand-alone systems and consumables. MolGen’s portfolio offers high-quality, adaptable, and safe workflows, which can be customised to meet customers’ specific needs.

MolGen Takes Part at SLAS Europe Fair in Dublin, Ireland

MolGen b.v. of Veenendaal (NL), a global solutions provider of innovative extraction DNA / RNA isolation technology, hardware, systems, consumables and reagents for human diagnostics, agricultural research, and the biotech industry is attending the SLAS Europe Fair, in Dublin, on the 24-27th of May 2022.

read more

Multiplex Respiratory viruses’ RT-qPCR kit: MoaA RT-q PCR kit by MolGen

The rapid and global spread of SARS-CoV-2 has impacted society heavily. This pandemic has placed both the world economy and health under pressure. To provide relief to populations, governments and businesses during these difficult times, MolGen has developed a high throughput, efficient and safe testing framework.

read more